Cargando…

Low Insulin-Like Growth Factor-1 Level in Obesity Nephropathy: A New Risk Factor?

INTRODUCTION: IGF-1 (insulin-like growth factor-1) is a hormone involved in cell growth and other important processes. In the kidney, IGF-1 has a stimulating effect, increasing the blood flow and glomerular filtration rate. Although many experimental animal studies regarding the role of IGF-1 in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bancu, Ioana, Navarro Díaz, Maruja, Serra, Assumpta, Granada, Marisa, Lopez, Dolores, Romero, Ramon, Bonet, Josep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854474/ https://www.ncbi.nlm.nih.gov/pubmed/27138941 http://dx.doi.org/10.1371/journal.pone.0154451

Ejemplares similares

Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy
por: Serra, Assumpta, et al.
Publicado: (2015)

Urinary Peptide Profiling to Differentiate between Minimal Change Disease and Focal Segmental Glomerulosclerosis
por: Pérez, Vanessa, et al.
Publicado: (2014)

Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling
por: Graterol, Fredzzia, et al.
Publicado: (2013)

Consequences of morbid obesity on the kidney. Where are we going?
por: Navarro Díaz, Maruja
Publicado: (2016)

Immunological Pattern in IgA Nephropathy
por: Esteve Cols, Clara, et al.
Publicado: (2020)

Frail Patient in Hemodialysis: A New Challenge in Nephrology—Incidence in Our Area, Barcelonès Nord and Maresme
por: Bancu, Ioana, et al.
Publicado: (2017)

The Insight into Insulin-Like Growth Factors and Insulin-Like Growth-Factor-Binding Proteins and Metabolic Profile in Pediatric Obesity
por: Czogała, Wojciech, et al.
Publicado: (2021)

The Insulin-like Growth Factor Signalling Pathway in Cardiac Development and Regeneration
por: Díaz del Moral, Sandra, et al.
Publicado: (2021)

Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis
por: Pérez, Vanessa, et al.
Publicado: (2017)

The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus
por: Lewitt, Moira S., et al.
Publicado: (2014)

Reduced Insulin-Like Growth Factor 1 Is Associated with Insulin Resistance in Obese Prepubertal Boys
por: Kuang, Jiangying, et al.
Publicado: (2021)

Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling
por: Yang, Shasha, et al.
Publicado: (2016)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Kruppel‐like factor 4 improves obesity‐related nephropathy through increasing mitochondrial biogenesis and activities
por: Jin, Lingwei, et al.
Publicado: (2019)

Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy
por: Gu, Tianwei, et al.
Publicado: (2014)

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy
por: Kabeer, Muhammad Asif, et al.
Publicado: (2020)

SNPs in the Insulin-Like Growth Factor Gene and Obesity Impact on Colorectal Cancer in Egyptians
por: Yosry, Ayman, et al.
Publicado: (2017)

Molecular profile of urine extracellular vesicles from normo-functional kidneys reveal minimal differences between living and deceased donors
por: Lozano-Ramos, S. Inés, et al.
Publicado: (2018)

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
por: Marshman, Emma, et al.
Publicado: (2002)

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
por: Lewitt, Moira S, et al.
Publicado: (2019)

Ramipril can alleviate the accumulation of renal mesangial matrix in rats with diabetic nephropathy by inhibiting insulin-like growth factor-1
por: Ren, Wei, et al.
Publicado: (2019)

The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes
por: Bermejo, Sheila, et al.
Publicado: (2023)

The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia
por: Moll, Lorna, et al.
Publicado: (2012)

A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
por: Westley, Rosalyne L., et al.
Publicado: (2013)

The Insulin-Like Growth Factor System
por: Roith, Derek Le
Publicado: (2003)

Insulin-like growth factors and cancer.
por: Macaulay, V. M.
Publicado: (1992)

In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1
por: Jafari, Elham, et al.
Publicado: (2018)

Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis
por: García-Fernández, María, et al.
Publicado: (2005)

The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes
por: Haywood, Natalie J., et al.
Publicado: (2018)

Insulin-like growth factor binding protein-3 links obesity and breast cancer progression
por: Scully, Tiffany, et al.
Publicado: (2016)

Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
por: Tian, Dan, et al.
Publicado: (2016)

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
por: Juega-Mariño, Javier, et al.
Publicado: (2017)

Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries
por: Mughal, Romana S, et al.
Publicado: (2018)

How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
por: Xu, Yibin, et al.
Publicado: (2022)

Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients
por: Pouriamehr, Somayeh, et al.
Publicado: (2019)

Effects of locally applied Insulin-like Growth Factor-I on osseointegration
por: López-Quiles, Juan, et al.
Publicado: (2019)

Elevated expression levels of serum insulin‐like growth factor‐1, tumor necrosis factor‐α and vascular endothelial growth factor 165 might exacerbate type 2 diabetic nephropathy
por: Li, Xiang, et al.
Publicado: (2016)

Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
por: Eller, Kathrin, et al.
Publicado: (2011)

Targeting insulin-like growth factor pathways
por: Yee, D
Publicado: (2006)

Insulin-like growth factors: the unrecognised oncogenes.
por: Westley, B. R., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_sli8rh82t7fsi6h2pfnsqgec51